Lv1
40 积分 2022-09-06 加入
Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240)
1个月前
已完结
The Antibody–Drug Conjugate Sacituzumab Govitecan (IMMU-132) Represents a Potential Novel Therapeutic Strategy in Cholangiocarcinoma
1个月前
已完结
First-line sacituzumab tirumotecan with tagitanlimab in advanced non-small-cell lung cancer: a phase 2 trial
4个月前
已完结
Electroacupuncture for Nausea, Vomiting, and Myelosuppression in Women Receiving Adjuvant Chemotherapy for Early Breast Cancer: A Randomized Controlled Pilot Trial
4个月前
已完结
Magnetic Resonance Imaging Findings of Microgeodic Disease of the Toe: A Case Report
4个月前
已完结
Mechanisms of ADC Toxicity and Strategies to Increase ADC Tolerability
4个月前
已完结
Antibody–drug conjugates in lung and breast cancer: current evidence and future directions—a position statement from the ETOP IBCSG Partners Foundation
5个月前
已完结
Mechanisms of resistance to antibody-drug conjugates in breast cancer
5个月前
已完结
Comprehensive clinical analysis of gastric-type endocervical adenocarcinoma: a real-world multicenter study
5个月前
已完结
Personalized care for patients with EGFR‐mutant nonsmall cell lung cancer: Navigating early to advanced disease management
6个月前
已完结
皖公网安备34019202002308
